SilverCrest Metals
SILV
Cars.com
CARS
Lantheus
LNTH
Collegium Pharmaceutical
COLL
Hutchmed (China)
HCM
(Q3)Nov 2, 2024 | (Q2)Aug 3, 2024 | (Q1)May 4, 2024 | (FY)Feb 3, 2024 | (Q4)Feb 3, 2024 | (Q3)Oct 28, 2023 | (Q2)Jul 29, 2023 | (Q1)Apr 29, 2023 | (FY)Jan 28, 2023 | (Q4)Jan 28, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | 252.19%173.48M | -158.53%-68.42M | -13.02%244.38M | -6.83%883.59M | 11.93%436.48M | -82.37%49.26M | 235.72%116.9M | -23.07%280.95M | -25.91%948.39M | -29.35%389.97M |
Net income from continuing operations | -19.79%124.6M | -43.36%74.48M | -10.65%180.04M | -17.14%738.85M | -13.38%250.5M | -17.33%155.34M | -19.54%131.51M | -19.75%201.5M | 3.38%891.64M | -9.98%289.19M |
Operating gains losses | 95.78%-171K | 91.88%-13K | 85.11%-267K | 71.24%-6.05M | 99.66%-47K | -202,550.00%-4.05M | -15,900.00%-160K | 75.22%-1.79M | 3.71%-21.05M | -690,250.00%-13.81M |
Depreciation and amortization | -1.50%44.43M | 3.65%46.87M | 0.78%46.52M | -4.66%181.18M | -6.98%44.7M | -4.14%45.11M | -6.41%45.22M | -0.97%46.16M | -5.66%190.03M | -9.53%48.05M |
Deferred tax | ---- | ---- | ---- | -15.85%-17.72M | ---- | ---- | ---- | ---- | -105.41%-15.3M | ---- |
Other non cash items | -98.10%-2.19M | -213.80%-3.87M | -69.91%-3.2M | -68.72%-5.68M | 33.97%-1.46M | 1.07%-1.11M | ---1.23M | ---1.88M | -215.99%-3.37M | ---2.21M |
Change In working capital | 104.67%6.81M | -218.11%-185.9M | -42.42%21.29M | 92.54%-6.98M | 90.97%160.51M | -420.76%-146.03M | 80.38%-58.44M | -50.52%36.97M | -138.58%-93.56M | -54.58%84.05M |
-Change in receivables | 19.13%2.73M | -2,237.48%-15.22M | 638.42%11.3M | 79.07%-3.6M | 80.97%-3.14M | 156.10%2.29M | 88.11%-651K | -123.69%-2.1M | -456.91%-17.18M | -45.74%-16.48M |
-Change in inventory | -12.43%-490.79M | -9.69%196.25M | -1.34%-293.69M | 165.47%26.21M | 2.03%535.25M | 3.28%-436.54M | 26.69%217.31M | -1.76%-289.81M | -627.75%-40.03M | 17.70%524.59M |
-Change in payables and accrued expense | 77.30%488.48M | -45.70%-379.4M | -2.59%313.75M | 42.69%-17.1M | 18.77%-354.3M | -45.03%275.51M | 43.93%-260.4M | -12.85%322.1M | -111.23%-29.84M | -66.18%-436.17M |
-Change in other current assets | -49.75%6.39M | 184.82%12.47M | -248.50%-10.07M | -91.67%-12.5M | -242.83%-17.3M | 6,332.35%12.71M | -3,099.80%-14.7M | 135.86%6.78M | 76.38%-6.52M | -49.77%12.11M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | 252.19%173.48M | -158.53%-68.42M | -13.02%244.38M | -6.83%883.59M | 11.93%436.48M | -82.37%49.26M | 235.72%116.9M | -23.07%280.95M | -25.91%948.39M | -29.35%389.97M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -145.45%-30.76M | 346.42%201.38M | -1,151.02%-230.78M | 50.99%-115.59M | -388.89%-123.51M | 132.90%67.68M | -40.65%-81.72M | 248.53%21.96M | -237.96%-235.85M | 273.73%42.75M |
Net PPE purchase and sale | 31.34%-28.06M | 17.64%-25.91M | -8.74%-35.18M | -10.69%-132.94M | -11.57%-28.27M | -21.36%-40.87M | 6.87%-31.46M | -18.44%-32.35M | -15.09%-120.11M | -2.93%-25.33M |
Net investment purchase and sale | -102.93%-2.93M | 549.57%227.28M | -473.78%-195.93M | 104.49%6.55M | -286.46%-95.32M | 158.09%100M | -105.03%-50.56M | --52.42M | ---145.7M | --51.12M |
Net other investing changes | -97.25%235K | -95.55%13K | -82.88%323K | -63.92%10.81M | -99.56%74K | 7,209.40%8.55M | -13.10%292K | -84.94%1.89M | -9.51%29.95M | 565,466.67%16.97M |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -145.45%-30.76M | 346.42%201.38M | -1,151.02%-230.78M | 50.99%-115.59M | -388.89%-123.51M | 132.90%67.68M | -40.65%-81.72M | 248.53%21.96M | -237.96%-235.85M | 273.73%42.75M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -121.30%-109.05M | 96.55%-4.06M | 96.19%-4.06M | 19.37%-620.04M | -13.63%-346.69M | -45.80%-49.28M | 47.77%-117.57M | 48.04%-106.5M | 9.94%-768.97M | 29.09%-305.1M |
Net issuance payments of debt | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -6,346.04%-44.8M | ---- |
Net common stock issuance | -128.28%-105M | --0 | --0 | 37.86%-281.41M | ---18.16M | -51.74%-45.99M | 48.44%-114.18M | 48.74%-103.08M | 16.89%-452.85M | --0 |
Cash dividends paid | -23.52%-4.06M | -19.57%-4.06M | -18.42%-4.06M | -24.81%-338.63M | -26.21%-328.53M | 5.82%-3.29M | 6.91%-3.39M | 11.70%-3.43M | 11.11%-271.31M | 11.91%-260.3M |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -121.30%-109.05M | 96.55%-4.06M | 96.19%-4.06M | 19.37%-620.04M | -13.63%-346.69M | -45.80%-49.28M | 47.77%-117.57M | 48.04%-106.5M | 9.94%-768.97M | 29.09%-305.1M |
Net cash flow | ||||||||||
Beginning cash position | 22.26%946.73M | -4.54%817.83M | 22.41%808.29M | -7.87%660.33M | 58.06%842M | 57.11%774.34M | -0.63%856.73M | -7.87%660.33M | 98.91%716.76M | -14.04%532.71M |
Current changes in cash | -50.24%33.66M | 256.45%128.9M | -95.14%9.54M | 362.20%147.96M | -126.42%-33.71M | 69.77%67.66M | 77.69%-82.39M | 35.06%196.4M | -115.83%-56.43M | 31.52%127.62M |
End cash Position | 16.44%980.39M | 22.26%946.73M | -4.54%817.83M | 22.41%808.29M | 22.41%808.29M | 58.06%842M | 57.11%774.34M | -0.63%856.73M | -7.87%660.33M | -7.87%660.33M |
Free cash flow | 1,634.24%145.42M | -210.40%-94.33M | -15.85%209.2M | -9.37%750.65M | 11.95%408.22M | -96.59%8.39M | 171.25%85.44M | -26.42%248.6M | -29.55%828.29M | -30.85%364.64M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |